✦ LIBER ✦

The use of CpG as an adjuvant toToxoplasma gondiivaccination

✍ Scribed by JenniferA. Spencer; BruceF. Smith; AnthonyJ. Guarino; ByronL. Blagburn; HenryJ. Baker

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of CpG oligodeoxynucleotides as immu

✍ Dennis M. Klinman; Debra Currie; Ihsan Gursel; Daniela Verthelyi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB

CpG oligonucleotide as an adjuvant for t

✍ David M. Lubaroff; Dev Karan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Safety and immunogenicity of CPG 7909 in

✍ C.L Cooper; H.L Davis; M.L Morris; S.M Efler; A.M Krieg; Y Li; C Laframboise; M. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 229 KB

CpG DNA functions as an effective adjuva

✍ B.M Manning; E.Y Enioutina; D.M Visic; A.D Knudson; R.A Daynes 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 502 KB

THE USE OF MORPHIA HYPODERMICALLY AS AN

✍ Currie, AndrewS. 📂 Article 📅 1882 🏛 The Lancet 🌐 English ⚖ 194 KB

Use of A-type CpG oligodeoxynucleotides

✍ G. Senti; P. Johansen; S. Haug; C. Bull; C. Gottschaller; P. Müller; T. Pfister; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB